Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
Just one weekly puff from an asthma-like inhaler might one day protect you from the viral infections that make winters miserable – and could even save your life in the event of another pandemic. That ...
Please provide your email address to receive an email when new articles are posted on . Interferon lambda-encoding messenger RNA drug ETH47 was generally safe in healthy individuals. A phase 2a trial ...
The United States may be losing its edge in mRNA technology. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...
Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback